Competitive advantages

VISCALGIC VS NSAIDS

  • VISCALGIC® avoids gastrointestinal side effects
  • VISCALGIC® avoids cardiovascular side effects
  • VISCALGIC® does not cause alterations in renal function
  • VISCALGIC® not only treats the symptoms of OA but also its causes

VISCALGIC VS CORTICOSTEROIDS

  • VISCALGIC® avoids the risk of damage to joint tissues
  • VISCALGIC® not only treats the symptoms of OA but also its causes
  • VISCALGIC® avoids patient discomfort and possible post-injection adverse events
  • VISCALGIC® avoids the lack of efficacy due to possible extra-articular needle placement

VISCALGIC VS Injectable viscosupplementation

  • VISCALGIC® not only supplements synovial fluid but also bone and cartilage
  • VISCALGIC® avoids patient discomfort and possible post-injection adverse events
  • VISCALGIC® avoids the lack of efficacy due to possible extra-articular needle placement
  • VISCALGIC® avoids the 24–48 h post-injection rest of the treated joint